Can Trump fix eggflation?
Inflation and scarcity afflicting America’s favorite breakfast have become a major political issue
Martin Vander Weyer is business editor of The Spectator. He writes the weekly Any Other Business column.
Inflation and scarcity afflicting America’s favorite breakfast have become a major political issue
On the platform of global affairs he’s wrongheaded, misanthropic and extremely dangerous
They shouldn’t be seduced by his pro-business, anti-woke agenda
There’s no disputing the potential to find everything from gold to rare earth elements. But the operating difficulties are truly formidable
Jimmy Lai has scant hope, barring a Trump intervention, of regaining his freedom
If realpolitik says an orderly plunder of Russian treasure might save Ukraine, then shouldn’t the rules change to allow it?
Complex globalized financial structures are capable of spreading damage everywhere
The former was an attention-seeking shameless fraudster. The latter was an oddball trading genius who was made a scapegoat
Lynch is pleading ‘not guilty’ to a San Francisco jury
Climate action must and surely will move forward, but so far the conference is a handful of desert sand
No one believes Beijing’s autocrats can intervene, manipulate or lie on the scale required to shore up the entire tottering $20 trillion economic colossus
The bank’s fate should have been decisively resolved by the Swiss authorities and its own board last fall
Outrage at any one-off windfall profit is generally pointless
Nayib Bukele has created a high-risk monetary experiment that excludes citizens who lack internet access
Any nation that’s well advanced in its vaccination program and has over-ordered should stop hoarding and start sending spare batches abroad
The $50 billion charity they created together has become the flagbearer for ‘venture philanthropy’
Will all this end in a bloodbath? Most likely
Bitcoiners own nothing but an evanescent idea
This battle will run for years and enrich armies of lawyers
Canny stock-pickers scan the pharmaceutical sector for claims of a first coronavirus vaccine